| Retail: $20 Approved for 1 Category A CE credit
Ryan J. Smith, D.H.Sc., CNMT
This presentation will discuss the theory and process behind radioimmunotherapy procedures, specifically In-111/Y-90 Zevalin therapy and I-131 Tositumomab therapy for Non-Hodgkin’s Lymphoma. The effects of ionizing radiation on cells will be briefly discussed leading into the therapy procedures. The effectiveness of the Antigen-Antibody reaction will be described along with the Human Anti-Mouse Antibody (HAMA) response that is associated with radioimmunotherapy procedures. Normal vs. Altered Bio-distribution of the radionuclides will be described along with corresponding treatment dosages and exposure rates.
Free access is included with membership. All titles for
which you have not previously earned CE credit appear in your CE library.
Not a member? Call Member Services to join 800-444-2778